ABCL

#1697
AbCellera Biologics Inc. - Common Shares
6.1 8 USD
+7.85%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
6.05
6.22
Rango anual
1.98
6.52
Cambio diario
+7.85%
Variación mensual
+59.28%
Variación en los últimos 6 meses
+71.19%
Cambio anual
+202.94%
Cierres anteriores
5.7 3
Open
6.0 6
Mínimo
6.0 5
High
6.2 2
Volumen
1 579
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 20212022202320242025 TTM

AbCellera Biologics Inc. - Common Shares

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Noticias